On Wednesday, Shares of SandRidge Energy Inc. (NYSE:SD), lost -6.77% to $0.505.
SandRidge Energy declared that it has designated Julian Bott as Executive Vice President and Chief Financial Officer of the company. Mr. Bott, who served as Chief Financial Officer at Texas American Resources Company since 2009, assumes the CFO role from Eddie M. LeBlanc, 66, who has served as CFO since July 2013 and has declared his retirement.
“On behalf of the entire SandRidge Energy team, I would like to thank Eddie for his leadership and contributions to our company,” commented James D. Bennett, Chief Executive Officer and President.
SandRidge Energy, Inc., an oil and natural gas company, explores for and produces oil and natural gas properties primarily in the Mid-Continent region of the United States. The company operates through three segments: Exploration and Production, Drilling and Oil Field Services, and Midstream Services.
Shares of Skyworks Solutions Inc (NASDAQ:SWKS), inclined 0.30% to $88.96, during its last trading session.
Skyworks Solutions declared that it will be the exclusive provider of RF content powering D-Links next generation 802.11ac Wave 2 devices. The AC5300 (DIR-895L/R) and AC3150 (DIR-885L/R) ultra Wi-Fi routers support tri-band 2.4 and 5 GHz technology, multiple user MIMO and deliver wireless speeds up to 5.3 Gbps and 3.2 Gbps, respectively. The DIR-895L/R is the world’s fastest router, facilitating uninterrupted, high definition multimedia streaming in the home.
“As new technologies emerge and more devices become connected within the home, consumers are demanding reliable, high-speed wide area network connections to carry data, voice, video and multimedia content simultaneously,” said AJ Wang, CTO of D-Link. “By leveraging Skyworks’ leading-edge Wave 2 connectivity solutions, we are able to offer customers the world’s fastest networking speeds and Wi-Fi connections for every type of mobile device, enhancing the user experience in the home.”
Skyworks Solutions, Inc., together with its auxiliaries, designs, develops, manufactures, and markets analog and mixed signal semiconductors worldwide. Its product portfolio comprises amplifiers, attenuators, battery chargers, circulators, DC/DC converters, demodulators, detectors, diodes, directional couplers, filters, front-end modules, hybrids, infrastructure radio frequency subsystems, isolators, LED drivers, mixers, modulators, optocouplers, optoisolators, phase shifters, phase locked loops/synthesizers/VCOs, power dividers/combiners, power administration devices, receivers, switches, technical ceramics, and voltage regulators.
Finally, Retrophin Inc (NASDAQ:RTRX), ended its last trade with 13.74% gain, and closed at $36.10.
Retrophin, stated its second quarter 2015 financial results.
- Net product sales for the second quarter 2015 were $24.1 million, contrast to net product sales of $5.7 million in the second quarter of 2014
- Non-GAAP operating income for the second quarter 2015 was $3.2 million, contrast to a non-GAAP operating loss of $11.5 million for the same period in 2014
- Cash, cash equivalents and marketable securities as of June 30, 2015 totaled $133.6 million
“We are very happy with the ongoing progress made in the second quarter,” said Stephen Aselage, Chief Executive Officer of Retrophin. “The 39 percent top-line enhance over the first quarter illustrates continued robust growth of Thiola and a strong start to the Cholbam launch. With the advancement of RE-024 into the clinic and the recent sale of our priority Review Voucher for $245 million, we continued to take meaningful steps to deliver long-term shareholder value.”
Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
